Golden
Vida Ventures

Vida Ventures

Vida Ventures is a bicoastal life sciences seed stage venture capital firm, founded in 2017 by a group of scientists, physicians, entrepreneurs, and investors. The firm's inaugural fund was raised in November 2017 and has $295 million in assets under management.

Vida Ventures was co-founded by Arie Belldegrun, Fred Cohen, Stefan Vitorovic, Joshua Kazam, Arjun Goyal and Len Potter. Vida Ventures is headquartered in Boston, Massachusetts.

Business history

In August 2017, it was reported that Vida Ventures has participated in a $83.5 million Series B financing round for Homology Medicines.

In December 2017, it was announced that Vida Ventures participated in a $62 million Series B financing round for Pionyr Therapeutics.

In March 2018, Homology Medicines, one of the companies Vida Ventures has invested in, began trading on the Nasdaq Global Select Market under the ticker "FIXX". Homology Medicines has raised $165 million in its initial public offering.

In April 2018, it was announced that Vida Ventures participated in a $300 million Series A financing round for Allogene Therapeutics.

In May 2018, it was announced that Vida Ventures participated in a $18 million seed financing round for Kronos Bio.

In July 2018, it was announced that Vida Ventures participated in a $85.4 Series E financing round for Sutro Biopharma.



Timeline

Associated investment funds

1 Result
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed
254,800,000
254,800,000
December 5, 2017

People

Name
Role
LinkedIn

Ankit Solanki

Advisor



Ishan Manaktala

Advisor



Karthik A Kulkarni

Advisor



Kenneth Leder

Advisor



Rohini Pandhi

Advisor



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

A2 Biotherapeutics

























Praxis Precision Medicines